Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Drugs for hypertriglyceridemia.

[No authors listed]

Med Lett Drugs Ther. 2013 Mar 4;55(1411):17-9. No abstract available.

PMID:
23467119
2.

[Update: clinical lipidology].

Parhofer KG.

MMW Fortschr Med. 2013 Jul 25;155(13):49-52; quiz 53-4. Review. German. No abstract available.

PMID:
23964509
3.

High-density lipoprotein cholesterol and triglycerides in the statin era: a pending issue?

Paillard F.

Arch Cardiovasc Dis. 2009 Mar;102(3):165-7. doi: 10.1016/j.acvd.2008.12.001. Epub 2009 Feb 23. No abstract available.

4.

Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.

Preiss D.

Expert Rev Gastroenterol Hepatol. 2013 Mar;7(3):193-5. doi: 10.1586/egh.12.79. No abstract available.

PMID:
23445227
5.

Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?

Scherer DJ, Nicholls SJ.

Vasc Health Risk Manag. 2015 Mar 25;11:203-9. doi: 10.2147/VHRM.S40134. eCollection 2015. Review.

6.

Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

Filippatos TD, Elisaf MS.

Curr Vasc Pharmacol. 2014;12(4):598-616. Review.

PMID:
23627980
7.

[Multimodal therapy of dyslipidemia].

Stahn A, Hanefeld M.

Clin Res Cardiol Suppl. 2011 May;6:10-6. Review. German.

PMID:
22528173
8.

First-line therapies for lowering triglyceride levels.

Raghavan VA.

Am Fam Physician. 2008 Feb 15;77(4):416; author reply 417-8. No abstract available.

9.

[Optimal lipid treatment: possibilities and current limitations].

Klose G.

Internist (Berl). 2011 Mar;52(3):328-35. doi: 10.1007/s00108-010-2799-7. German.

PMID:
21331642
10.

Hypertriglyceridemia and cardiovascular disease management.

Codario RA.

J Am Acad Nurse Pract. 2007;19(12 Suppl 2):7-10, 13-4. No abstract available.

PMID:
18510282
11.

Treating hypertriglyceridemia.

Holub BJ.

CMAJ. 2007 Sep 11;177(6):604; author reply 604-5. No abstract available.

12.

Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.

Ito MK.

Atherosclerosis. 2015 Oct;242(2):647-56. doi: 10.1016/j.atherosclerosis.2015.06.012. Epub 2015 Jun 11. Review.

PMID:
26296750
13.

Management of hypertriglyceridemia in the diabetic patient.

Jialal I, Amess W, Kaur M.

Curr Diab Rep. 2010 Aug;10(4):316-20. doi: 10.1007/s11892-010-0124-4. Review.

14.

(8) Cardiovascular disease and risk management.

American Diabetes Association.

Diabetes Care. 2015 Jan;38 Suppl:S49-57. doi: 10.2337/dc15-S011. No abstract available.

PMID:
25537708
15.

Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.

Endocrine Society.

Am Fam Physician. 2013 Jul 15;88(2):142-4. No abstract available.

16.

Bridging the gap in treatment options for patients with hypertriglyceridemia.

Underberg JA, Hays R.

J Fam Pract. 2007 Dec;56(12 Suppl New):S24-31. Review.

PMID:
18664339
17.

Paradoxical decrease in serum high-density lipoprotein cholesterol with Tredaptive® (m/r nicotinic acid 1 g and laropiprant 20 mg).

Sharpe P.

Ann Clin Biochem. 2011 Nov;48(Pt 6):584-5. doi: 10.1258/acb.2011.011081. Epub 2011 Aug 25. No abstract available.

18.

Triglycerides: a case for treatment?

Wierzbicki AS, Clarke RE, Viljoen A, Mikhailidis DP.

Curr Opin Cardiol. 2012 Jul;27(4):398-404. doi: 10.1097/HCO.0b013e328353adc1. Review.

PMID:
22565137
19.

Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.

Brinton EA.

Cardiol Clin. 2015 May;33(2):309-23. doi: 10.1016/j.ccl.2015.02.007. Review.

PMID:
25939302
20.

Dyslipidaemia: Failure to THRIVE: the end for niacin?

Wierzbicki AS.

Nat Rev Cardiol. 2013 May;10(5):246-7. doi: 10.1038/nrcardio.2013.48. Epub 2013 Apr 2. No abstract available.

PMID:
23546446
Items per page

Supplemental Content

Write to the Help Desk